5th Bladder Cancer Translational Research Meeting 2023

The Bladder Cancer Research Centre   (University of Birmingham) and the Translational Oncology & Urology   Research (TOUR) team (King’s College London and Guy’s Hospital) are organising their 5th  Bladder Cancer Translational Research Meeting - a fully interactive   bladder cancer clinical research meeting led by an international expert panel   of clinicians and scientists in the U.K. The forum is designed to bridge the   gap between science and clinical practice and will cover the spectrum of   bladder cancer research in oncology, urology, nursing, epidemiology, immuno-   and molecular biology.

Despite   the substantial disease burden for patients and healthcare providers, bladder   cancer only receives 0.6% of cancer research spending. This meeting will thus   provide an opportunity to enhance collaborations across the UK and   internationally and allow networking opportunities between clinicians and   scientists allowing participants to anticipate crucial observations in the   clinical practice to inform research activities and vice versa. Marrying   these two diverse disciplines will enable healthcare systems to provide more   efficient outcome-driven patient-centred interventions in the field of   bladder cancer.

In   addition to engagement through interactive sessions with high impact   speakers, we invite participants from their respective units to submit   and present their research. Three high impact abstracts will be   selected for an oral presentation and the best oral and poster presentations   will be awarded with a prize.

Edgbaston Park Hotel and   Conference Centre is the venue for this   translational research event on Monday 27th March 2023 and we look   forward to welcoming delegates to another exciting meeting.

Abstract submission:

Abstracts need to be submitted to saran.green@kcl.ac.uk  by 15th March 2023. Abstracts should be structured (background,   methods, results, conclusion) and be no longer than 300 words.  All   authors should be listed, including their affiliation.